I Worked for Big Pharma: What I Saw Will Shock You
Some of the ways that I saw the bribes start: First one I saw was a rep came in and invited a doctor to Bimini for a five-day snorkeling vacation. And I almost passed out when I heard that. One rep from California said, “Well, I bought my doctor a $15,000 Birkin handbag.” The other […]
What Big Pharma Knew… and When
Over the last several years, people have started to question the medical experts. Obviously, after COVID there were a lot of us who had questions because we felt like we were not only being misled but deliberately lied to for asking questions, and now that has carried over into a lot of other areas that […]
Former FDA Director Regulating Vaccines Joins Eli Lilly
The former director of the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER), Peter Marks, MD, PhD, who was responsible for the agency’s regulation of the safety and effectiveness of vaccines, joined drug giant Eli Lilly and Company after resigning from the agency on Mar. 28, 2025.1 Dr. Marks alleged […]
Doctors Took Their Vaccine Information from Big Pharma & the BBC | Aseem Malhorta, MD
At the end of 2021 when the [COVID-19] vaccine mandates was a big story being pushed on health care workers, I instantly knew this was coming from the drug industry because by the summer of 2021 we knew [the vaccines] were not stopping infection, weren’t stopping transmission, and there was already serious harms being reported. […]
FDA Official Leaves Agency Through the “Revolving Door” and Returns to Pfizer
On Feb. 24,2025, Pfizer, Inc. announced that FDA official Patrizia Cavazzoni, MD will rejoin the pharmaceutical company, which makes and sells federally recommended vaccines and drugs, as Pfizer’s Chief Medical Officer and Executive Vice President. Most recently, Dr. Cavazzoni served as Director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food […]
China’s Biotech Boom Reshapes Pharma, Sparks U.S. Industry Concerns
It appears there’s a China biotech gold rush as U.S. investors and pharma giants look to the world’s second largest economy in a new quest for new drugs and new remedies. Everyone is talking about China right now. Almost 30 percent of Big Pharma deals worth at least $50 million upfront came from China last […]